OpenLegislation

Division 1.3 Summary of product characteristics, labelling and package leafletF1

United Kingdom

Original text. Later amendments are not shown.

  1. 1.3.1Summary of product characteristics
  2. 1.3.2Labelling and package leaflet
  3. 1.3.3Mock-ups and specimens
  4. 1.3.4Summaries of product characteristics already approved in the Member States

Annotations

Textual amendments

F1

Substituted by Commission directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use (Text with EEA relevance).